Sirvan Khalighi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sirvan Khalighi has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Urbano Nunes
University of Coimbra
9 shared publications - Teresa Sousa
Coimbra Institute for Biomedical Imaging and Translational Research (CIBIT), University of Coimbra, Portugal
6 shared publications Parisa Tirdad
Concordia University
5 shared publications- Gabriel Pires
Institute of Systems and Robotics, University of Coimbra, Coimbra, Portugal
4 shared publications - Hamid Reza Rabiee
Affiliation Department of Computer Engineering, Sharif University of Technology, Tehran, Iran
3 shared publications - Ali Jahanian
Faculty of Computer Science and Engineering, Shahid Beheshti University, Tehran, Iran
2 shared publications
Latest Publications
- Top Cited PapersOpen Access
- 29 March 2024
- Published by Springer Nature in npj Precision Oncology
- Vol. 8 (1) , 1-12
Artificial intelligence in neuro-oncology: advances and challenges in brain tumor diagnosis, prognosis, and precision treatment
This review delves into the most recent advancements in applying artificial intelligence (AI) within neuro-oncology, specifically emphasizing work on gliomas, a class of brain tumors that represent a significant global health issue. AI has brought transformative innovations to brain tumor management, utilizing imaging, histopathological, and genomic tools for efficient detection, categorization, outcome prediction, and treatment planning. Assessing its influence across all facets of malignant brain tumor management- diagnosis, prognosis, and therapy- AI models outperform human evaluations in terms of accuracy and specificity. Their ability to discern molecular aspects from imaging may reduce reliance on invasive diagnostics and may accelerate the time to molecular diagnoses. The review covers AI techniques, from classical machine learning to deep learning, highlighting current applications and challenges. Promising directions for future research include multimodal data integration, generative AI, large medical language models, precise tumor delineation and characterization, and addressing racial and gender disparities. Adaptive personalized treatment strategies are also emphasized for optimizing clinical outcomes. Ethical, legal, and social implications are discussed, advocating for transparency and fairness in AI integration for neuro-oncology and providing a holistic understanding of its transformative impact on patient care.
- 29 March 2024
- Published by Springer Nature in npj Precision Oncology
- Vol. 8 (1) , 1-12
Top Cited PapersOpen AccessArtificial intelligence in neuro-oncology: advances and challenges in brain tumor diagnosis, prognosis, and precision treatment
This review delves into the most recent advancements in applying artificial intelligence (AI) within neuro-oncology, specifically emphasizing work on gliomas, a class of brain tumors that represent a significant global health issue. AI has brought transformative innovations to brain tumor management, utilizing imaging, histopathological, and genomic tools for efficient detection, categorization, outcome prediction, and treatment planning. Assessing its influence across all facets of malignant brain tumor management- diagnosis, prognosis, and therapy- AI models outperform human evaluations in terms of accuracy and specificity. Their ability to discern molecular aspects from imaging may reduce reliance on invasive diagnostics and may accelerate the time to molecular diagnoses. The review covers AI techniques, from classical machine learning to deep learning, highlighting current applications and challenges. Promising directions for future research include multimodal data integration, generative AI, large medical language models, precise tumor delineation and characterization, and addressing racial and gender disparities. Adaptive personalized treatment strategies are also emphasized for optimizing clinical outcomes. Ethical, legal, and social implications are discussed, advocating for transparency and fairness in AI integration for neuro-oncology and providing a holistic understanding of its transformative impact on patient care.
- 9 July 2022
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 23 (4)
SYSMut: decoding the functional significance of rare somatic mutations in cancer
Current tailored-therapy efforts in cancer are largely focused on a small number of highly recurrently mutated driver genes but therapeutic targeting of these oncogenes remains challenging. However, the vast number of genes mutated infrequently across cancers has received less attention, in part, due to a lack of understanding of their biological significance. We present SYSMut, an extendable systems biology platform that can robustly infer the biologic consequences of somatic mutations by integrating routine multiomics profiles in primary tumors. We establish SYSMut’s improved performance vis-à-vis state-of-the-art driver gene identification methodologies by recapitulating the functional impact of known driver genes, while additionally identifying novel functionally impactful mutated genes across 29 cancers. Subsequent application of SYSMut on low-frequency gene mutations in head and neck squamous cell (HNSC) cancers, followed by molecular and pharmacogenetic validation, revealed the lipidogenic network as a novel therapeutic vulnerability in aggressive HNSC cancers. SYSMut is thus a robust scalable framework that enables the discovery of new targetable avenues in cancer.
- 9 July 2022
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 23 (4)
SYSMut: decoding the functional significance of rare somatic mutations in cancer
Current tailored-therapy efforts in cancer are largely focused on a small number of highly recurrently mutated driver genes but therapeutic targeting of these oncogenes remains challenging. However, the vast number of genes mutated infrequently across cancers has received less attention, in part, due to a lack of understanding of their biological significance. We present SYSMut, an extendable systems biology platform that can robustly infer the biologic consequences of somatic mutations by integrating routine multiomics profiles in primary tumors. We establish SYSMut’s improved performance vis-à-vis state-of-the-art driver gene identification methodologies by recapitulating the functional impact of known driver genes, while additionally identifying novel functionally impactful mutated genes across 29 cancers. Subsequent application of SYSMut on low-frequency gene mutations in head and neck squamous cell (HNSC) cancers, followed by molecular and pharmacogenetic validation, revealed the lipidogenic network as a novel therapeutic vulnerability in aggressive HNSC cancers. SYSMut is thus a robust scalable framework that enables the discovery of new targetable avenues in cancer.
- Open Access
- 18 May 2022
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 119 (21)
H3K9 methylation drives resistance to androgen receptor–antagonist therapy in prostate cancer
Significance: This study reveals that antiandrogen therapy induces viral mimicry responses that are crucial for antitumor activity. H3K9 trimethylation to silence endogenous repeat elements is essential for regaining heterochromatin stability and progression to antiandrogen resistance in prostate cancer. We found that the H3K9 trimethylation machinery is linked to poor outcomes in men with prostate cancer. Blockade of this epigenetic axis can resensitize drug-resistant tumors and elicit cytotoxic interferon responses. Antiandrogen timing and regulation of the H3K9 methylation–endogenous repeat elements– interferon axis should be considered in the development of novel epigenetic therapies and immunotherapeutic strategies for prostate cancer.
- 18 May 2022
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 119 (21)
Open AccessH3K9 methylation drives resistance to androgen receptor–antagonist therapy in prostate cancer
Significance: This study reveals that antiandrogen therapy induces viral mimicry responses that are crucial for antitumor activity. H3K9 trimethylation to silence endogenous repeat elements is essential for regaining heterochromatin stability and progression to antiandrogen resistance in prostate cancer. We found that the H3K9 trimethylation machinery is linked to poor outcomes in men with prostate cancer. Blockade of this epigenetic axis can resensitize drug-resistant tumors and elicit cytotoxic interferon responses. Antiandrogen timing and regulation of the H3K9 methylation–endogenous repeat elements– interferon axis should be considered in the development of novel epigenetic therapies and immunotherapeutic strategies for prostate cancer.
- Open Access
SYS-Mut: Decoding the Functional Significance of Rare Somatic Mutations in Cancer
Current tailored-therapy efforts in cancer are largely focused on a small number of highly recurrently-mutated driver genes but therapeutic targeting of these oncogenes remains challenging. On the other hand, the vast number of genes mutated infrequently across cancers have received less attention, in part, due to a lack of understanding of their biologic significance. Here we present SYS-Mut, a systems biology platform that can robustly infer the biologic consequences of somatic mutations by integrating routine multi-omic profiles in primary tumors. We established the accuracy of SYS-Mut by recapitulating the functional impact of known driver genes in PanCancer datasets. Subsequent application of SYS-Mut on low-frequency gene mutations in Head and Neck Cancers (HNSC), followed by molecular and pharmacogenetic validation, revealed the lipidogenic network as a novel therapeutic vulnerability in aggressive HNSC. SYS-Mut is thus a robust scalable framework that enables discovery of new targetable avenues in cancer.
Open AccessSYS-Mut: Decoding the Functional Significance of Rare Somatic Mutations in Cancer
Current tailored-therapy efforts in cancer are largely focused on a small number of highly recurrently-mutated driver genes but therapeutic targeting of these oncogenes remains challenging. On the other hand, the vast number of genes mutated infrequently across cancers have received less attention, in part, due to a lack of understanding of their biologic significance. Here we present SYS-Mut, a systems biology platform that can robustly infer the biologic consequences of somatic mutations by integrating routine multi-omic profiles in primary tumors. We established the accuracy of SYS-Mut by recapitulating the functional impact of known driver genes in PanCancer datasets. Subsequent application of SYS-Mut on low-frequency gene mutations in Head and Neck Cancers (HNSC), followed by molecular and pharmacogenetic validation, revealed the lipidogenic network as a novel therapeutic vulnerability in aggressive HNSC. SYS-Mut is thus a robust scalable framework that enables discovery of new targetable avenues in cancer.
- 27 October 2016
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Cybernetics
- Vol. 47 (10) , 3280-3292
Importance Weighted Import Vector Machine for Unsupervised Domain Adaptation
In real-world applications, the assumption of independent and identical distribution is no longer consistent. To alleviate the significant mismatch between source and target domains, importance weighting import vector machine, which is an adaptive classifier, is proposed. This adaptive probabilistic classification method, which is sparse and computationally efficient, can be used for unsupervised domain adaptation (DA). The effectiveness of the proposed approach is demonstrated via a toy problem, and a real-world cross-domain object recognition task. Even though the sparseness, the proposed method outperforms the state-of-the-art in both unsupervised and semisupervised DA scenarios. We also introduce a reliable importance weighted cross validation (RIWCV), which is an improvement of importance weighted cross validation, for parameter and model selection. The RIWCV avoid falling down in local minimum, by selecting a more reliable combination of the parameters instead of the best parameters.
- 27 October 2016
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Cybernetics
- Vol. 47 (10) , 3280-3292
Importance Weighted Import Vector Machine for Unsupervised Domain Adaptation
In real-world applications, the assumption of independent and identical distribution is no longer consistent. To alleviate the significant mismatch between source and target domains, importance weighting import vector machine, which is an adaptive classifier, is proposed. This adaptive probabilistic classification method, which is sparse and computationally efficient, can be used for unsupervised domain adaptation (DA). The effectiveness of the proposed approach is demonstrated via a toy problem, and a real-world cross-domain object recognition task. Even though the sparseness, the proposed method outperforms the state-of-the-art in both unsupervised and semisupervised DA scenarios. We also introduce a reliable importance weighted cross validation (RIWCV), which is an improvement of importance weighted cross validation, for parameter and model selection. The RIWCV avoid falling down in local minimum, by selecting a more reliable combination of the parameters instead of the best parameters.
- Top Cited Papers
- 1 February 2016
- Published by Elsevier in Computer Methods and Programs in Biomedicine
- Vol. 124, 180-192
ISRUC-Sleep: A comprehensive public dataset for sleep researchers
- 1 February 2016
- Published by Elsevier in Computer Methods and Programs in Biomedicine
- Vol. 124, 180-192
Top Cited PapersISRUC-Sleep: A comprehensive public dataset for sleep researchers
- 1 April 2015
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 59, 42-53
A two-step automatic sleep stage classification method with dubious range detection
- 1 April 2015
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 59, 42-53
A two-step automatic sleep stage classification method with dubious range detection
- 24 June 2014
- Published by Springer Nature in Journal of Signal Processing Systems
- Vol. 81 (1) , 111-128
Iris Recognition using Robust Localization and Nonsubsampled Contourlet Based Features
- 24 June 2014
- Published by Springer Nature in Journal of Signal Processing Systems
- Vol. 81 (1) , 111-128
Iris Recognition using Robust Localization and Nonsubsampled Contourlet Based Features
- 1 December 2013
- Published by Elsevier in Expert Systems with Applications
- Vol. 40 (17) , 7046-7059
Automatic sleep staging: A computer assisted approach for optimal combination of features and polysomnographic channels
- 1 December 2013
- Published by Elsevier in Expert Systems with Applications
- Vol. 40 (17) , 7046-7059
Automatic sleep staging: A computer assisted approach for optimal combination of features and polysomnographic channels
- 1 August 2012
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- Vol. 8 (1094687X) , 2259-2262
Adaptive automatic sleep stage classification under covariate shift
Current automatic sleep stage classification (ASSC) methods that rely on polysomnographic (PSG) signals suffer from inter-subject differences that make them unreliable in facing with new and different subjects. A novel adaptive sleep scoring method based on unsupervised domain adaptation, aiming to be robust to inter-subject variability, is proposed. We assume that the sleep quality variants follow a covariate shift model, where only the sleep features distribution change in the training and test phases. The maximum overlap discrete wavelet transform (MODWT) is applied to extract relevant features from EEG, EOG and EMG signals. A set of significant features are selected by minimum-redundancy maximum-relevance (mRMR) which is a powerful feature selection method. Finally, an instance-weighting method, namely the importance weighted kernel logistic regression (IWKLR) is applied for the purpose of obtaining adaptation in classification. The classification results using leave one out cross-validation (LOOCV), show that the proposed method performs at the state-of-the art in the field of ASSC.
- 1 August 2012
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- Vol. 8 (1094687X) , 2259-2262
Adaptive automatic sleep stage classification under covariate shift
Current automatic sleep stage classification (ASSC) methods that rely on polysomnographic (PSG) signals suffer from inter-subject differences that make them unreliable in facing with new and different subjects. A novel adaptive sleep scoring method based on unsupervised domain adaptation, aiming to be robust to inter-subject variability, is proposed. We assume that the sleep quality variants follow a covariate shift model, where only the sleep features distribution change in the training and test phases. The maximum overlap discrete wavelet transform (MODWT) is applied to extract relevant features from EEG, EOG and EMG signals. A set of significant features are selected by minimum-redundancy maximum-relevance (mRMR) which is a powerful feature selection method. Finally, an instance-weighting method, namely the importance weighted kernel logistic regression (IWKLR) is applied for the purpose of obtaining adaptation in classification. The classification results using leave one out cross-validation (LOOCV), show that the proposed method performs at the state-of-the art in the field of ASSC.